FindTrial
Sign In

Vasopressin and Steroids in addition to Adrenaline in cardiac arrest -a randomized clinical trial

Status
Suspended
Phases
Phase 3
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2025-521283-35-00
Enrollment
1400
Registered
2025-04-02
Start date
2025-04-02
Completion date
Unknown
Last updated
2025-04-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac arrest

Brief summary

Survival at 30 days

Interventions

DRUGSolu-Cortef 100 mg pulver och vätska till injektionsvätska
DRUGlösning.
DRUGAdrenalin Aguettant 0
DRUG1 mg/ml
DRUGinjektionsvätska
DRUGlösning i förfylld spruta
DRUGSolu-Medrol 40 mg pulver och vätska till injektionsvätska
DRUGlösning
DRUGEmpressin 40 IE/2 ml koncentrat till infusionsvätska

Sponsors

Tiohundra AB
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Design outcomes

Primary

MeasureTime frame
Survival at 30 days—

Countries

Sweden

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026